Health Canada
- Status: approved
Platelet rich plasma intrauterine infusion (Platelet rich plasma intrauterine infusion) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Tanta University is the originator. The local marketing authorisation holder may differ — check the official source linked above.